FDA approval of HAVRIX (hepatitis A vaccine, inactivated) for persons aged 1-18 years.
| Publicado en: | MMWR: Morbidity & Mortality Weekly Report Vol. 54; no. 48; pp. 1235 - 1237 |
|---|---|
| Formato: | brief item Journal Article |
| Publicado: |
Centers for Disease Control & Prevention (CDC)
12/9/2005
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106380584&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 106380584 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 01492195 MMW jtl: MMWR: Morbidity & Mortality Weekly Report issn: 01492195 maglogo: N pubinfo: dt: 12/9/2005 vid: 54 iid: 48 pid: 1493 pub: Centers for Disease Control & Prevention (CDC) place: Atlanta, Georgia artinfo: ui: 106380584 106380584 2009077140 106380584 ppf: 1235 ppct: 2 formats: fmt: @attributes: type: P tig: atl: FDA approval of HAVRIX (hepatitis A vaccine, inactivated) for persons aged 1-18 years. aug: sug: subj: Drug Approval Hepatitis A Prevention and Control United States Food and Drug Administration Viral Hepatitis Vaccines Adolescence Child Child, Preschool Adolescent: 13-18 years Child: 6-12 years Child, Preschool: 2-5 years pubtype: Academic Journal doctype: brief item Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|